Novel Collagen Scaffold vs Conventional Scaffold in Regeneration of Human Dental Pulp Tissue

Withdrawn before enrolling · Phase 2

Conditions studied: Root Canal Therapy

In brief

The purpose of this investigation is to assess the use of a novel scaffold (an FDA-approved collagen-hydroxyapatite material called Syn-Oss) for regeneration of pulp tissues versus the use of a traditional scaffold (blood clot).

Key facts

Study ID

NCT03613090

Run by

University of Alabama at Birmingham

People needed

0

Starts

2019-04-01

Expected to finish

2019-04-01

Last updated by the study team

2019-05-23

Who can join

Age: 12 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Single root canal space apparent on a standard dental periapical radiograph
• Immature tooth apex width at least 1.1mm in diameter as measured from the radiograph
• No history of antibiotic drug allergy
• Necrotic pulp as demonstrated by coronal discoloration.
• Periapical radiolucency
• Negative pulp sensibility tests
• Other standard clinical means of assessing pulp vitality status

You may not qualify if…

• Any patients having an American Association of Anesthesiologists 4 health classification will be excluded.

Where it is running

• University of Alabama at Birmingham — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.